These studies showed that CHPF was overexpressed in lung adenocarcinoma, non-small-cell lung cancer, hepatocellular carcinoma, malignant melanoma, and breast carcinoma [14, 15, 27–34]. This evidence concerns the gene CHPF and hepatocellular carcinoma.